Bezlotoxumab - in "Real Life" - During the First Episode of Clostridium Difficile Infection in Patients With High Risk of Recurrence.

NCT04075422 · clinicaltrials.gov ↗
COMPLETED
Status
869
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Fundacion SEIMC-GESIDA

Collaborators